Sintons is supporting excellence in the North East’s biomedical sector by becoming a sponsor of the 2013 Biomedical
The awards, hosted by Bionow and previously known as the Business for Life Awards, celebrate the strength and depth of the cluster and the diversity of the companies within the biomedical sector across the North of England.
The winners of each category will be announced at an awards ceremony taking place on Thursday 28 February 2013 at the BALTIC Centre for Contemporary Art on Gateshead Quays.
The awards received huge response from a range of companies within the sector, and 16 finalists were chosen from the scores of entries.
Sintons is the sponsor of the outstanding growth category, one of five categories in the 2013 Biomedical Awards, alongside excellence in export, innovation and technology, partnership/collaboration of the year and promising technologist of the year.
Anthony Evans, Partner in the Company and Commercial department at Sintons, said: “The North of England is a region with a huge amount of both established and emerging expertise in this sector, and we have businesses based here which lead the way regionally and nationally. With Sintons’ enviable reputation for its work in supporting businesses, as well as our expertise in the medical sector, we are very pleased to be able to support these awards and help recognise the talent we have here.”
The North of England is one of the UK’s and Europe’s largest biomedical regions around a quarter of the UK’s biomedical companies, employment and turnover are in the North. Comprising over 1,000 life science and healthcare companies, it generates a turnover of £10.9bn and employs more than 38,000 people. The area is home to the N8 Research Partnership and boasts world-leading resources in terms of investment, scientific expertise, academic research, science graduates, NHS hospitals and state-of-the-art manufacturing facilities.
Geoff Davison, CEO of Bionow, said: “We have received many high-calibre entries for this year’s Biomedical Awards which demonstrate the amazing capability and versatility of the biomedical sector across the North of England. The quality and number of nominations has been outstanding and the judges were impressed with the progress and development of the companies who entered this year. The final 16 are a group of forward-thinking companies which are testament to the strength and vast potential of the sector.”
